| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdominal Adipose Tissue Metabolism in Human Ectopic Fat and Cardiometabolic Risk
|
Hoyle, Brian
|
|
2013
|
|
16 |
p. 6-7
|
artikel
|
| 2 |
Abdominal Obesity in Asia: Current Trends
|
Mosley, Mary
|
|
2013
|
|
16 |
p. 4-5
|
artikel
|
| 3 |
Dapagliflozin Does Not Impact Renal Function in Patients with Type 2 Diabetes
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 21-21
|
artikel
|
| 4 |
Diabetes and Enterovirus Infection: The Evidence and Implications
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 24-25
|
artikel
|
| 5 |
DiaPep277® Shows Promise as a Therapeutic Strategy for Type 1 Diabetes
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 14-15
|
artikel
|
| 6 |
EASD/ESC Symposium: Renal Denervation
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 32-33
|
artikel
|
| 7 |
Evidence Base for Nutrition Recommendations for CVD Prevention
|
Hand, Larry
|
|
2013
|
|
16 |
p. 20-21
|
artikel
|
| 8 |
Exenatide Once Weekly Sustained Improvement in Glycemic Control with Weight Loss through 4 Years
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 13-14
|
artikel
|
| 9 |
Exercise and Healthy Diet for Management of Abdominal Obesity
|
Rizzo, Toni
|
|
2013
|
|
16 |
p. 14-15
|
artikel
|
| 10 |
Extending the Reach of GLP-1
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 28-29
|
artikel
|
| 11 |
Human Genetics and Type 2 Diabetes: Behind the Headlines
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 30-31
|
artikel
|
| 12 |
Hypertension and Renal Function are Risk Factors for CAD in Type 1 Diabetes
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 34-34
|
artikel
|
| 13 |
Hypertrophic Obesity is Associated with Inflammation and Insulin Resistance
|
Rizzo, Toni
|
|
2013
|
|
16 |
p. 10-11
|
artikel
|
| 14 |
Impact of Abdominal Obesity on CVD and Diabetes
|
Mosley, Mary
|
|
2013
|
|
16 |
p. 16-17
|
artikel
|
| 15 |
Inflammation, Adipose Tissue, and Cardiometabolic Risk
|
Mosley, Mary
|
|
2013
|
|
16 |
p. 8-9
|
artikel
|
| 16 |
Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Uncontrolled Patients with Type 2 Diabetes on Oral Agents
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 20-20
|
artikel
|
| 17 |
Linagliptin Proves Safe and Effective as Add-on Therapy to Basal Insulin
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 15-16
|
artikel
|
| 18 |
Management of Cardiovascular Risk Factors in Asymptomatic Patients with Hypertension
|
Hoyle, Brian
|
|
2013
|
|
16 |
p. 13-14
|
artikel
|
| 19 |
New ADA/EASD Guidelines Focus on Patient-Centered Care
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 9-11
|
artikel
|
| 20 |
Novel Oral Agents: The Search for Transformational Medicines
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 26-27
|
artikel
|
| 21 |
Obesity, Adiponectin, and Cardiometabolic Risk
|
Mosley, Mary
|
|
2013
|
|
16 |
p. 9-9
|
artikel
|
| 22 |
ORIGIN Trial: Insulin Glargine and n-3 Fatty Acids Neither Reduces CV Events Nor Increases Cancers in Diabetic Patients
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 12-13
|
artikel
|
| 23 |
Oversupply of Free Fatty Acids to the Systemic Circulation is Not a Distinct Feature of Insulin Resistance or Obesity
|
Rizzo, Toni
|
|
2013
|
|
16 |
p. 11-12
|
artikel
|
| 24 |
Population-Based Screening for Type 2 Diabetes: The ADDITION-Cambridge Trial
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 21-22
|
artikel
|
| 25 |
PPAR-Mediated Mechanisms of Skeletal Muscle Insulin Resistance
|
Parry, Nicola
|
|
2013
|
|
16 |
p. 12-13
|
artikel
|
| 26 |
Resistin Receptor Mediates Inflammatory Actions
|
Hoyle, Brian
|
|
2013
|
|
16 |
p. 7-7
|
artikel
|
| 27 |
Role of iNKT Cells in Adipose Tissue Inflammation and Insulin Resistance
|
Rizzo, Toni
|
|
2013
|
|
16 |
p. 10-10
|
artikel
|
| 28 |
Statins in the Management of LDL-C
|
Hoyle, Brian
|
|
2013
|
|
16 |
p. 22-23
|
artikel
|
| 29 |
Storage of Dietary Fatty Acids in Type 2 Diabetes
|
Mosley, Mary
|
|
2013
|
|
16 |
p. 7-8
|
artikel
|
| 30 |
Targeting Abdominal Obesity in Diabetology
|
Hoyle, Brian
|
|
2013
|
|
16 |
p. 18-19
|
artikel
|
| 31 |
The Challenges of Pharmaceutical Management of Painful Diabetic Peripheral Neuropathy
|
Buckley, Rita
|
|
2012
|
|
16 |
p. 23-23
|
artikel
|
| 32 |
Thermogenesis-Based Obesity Interventions
|
Parry, Nicola
|
|
2013
|
|
16 |
p. 13-13
|
artikel
|
| 33 |
Understanding Incretin Hormone Action and the Treatment of Diabetes
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 6-8
|
artikel
|
| 34 |
12-Week Treatment with LY2409021 Significantly Lowers HbA1C and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus
|
Vinall, Maria
|
|
2012
|
|
16 |
p. 16-17
|
artikel
|
Tijdschrift beschrijving